SF1126, a Pan-PI3K Inhibitor Has Superior Preclinical Activity to CAL-101 a PI3K Delta-Specific Inhibitor in Aggressive B-Cell Non-Hodgkin's Lymphoma
- Resource Type
- Abstract
- Source
- In
Blood 18 November 2011 118(21):2720-2720 - Subject
- Language
- ISSN
- 0006-4971